Status:
UNKNOWN
Is Serum YKL-40 Capable of Predicting Intrauterine Growth Restriction (IUGR) and Preeclampsia?
Lead Sponsor:
Zealand University Hospital
Collaborating Sponsors:
Region Zealand
University of Copenhagen
Conditions:
Intrauterine Growth Restriction
Preeclampsia
Eligibility:
FEMALE
18-50 years
Brief Summary
Objective: To investigate the role of maternal serum YKL-40 and uterine artery doppler, at gestational age 12, 20, 25 and 32 weeks, and the relation to preeclampsia and intrauterine growth restriction...
Eligibility Criteria
Inclusion
- Pregnant danish speeking women
Exclusion
- Conditions/diseases involving chronical inflammation, or immunological activity
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2012
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00836524
Start Date
January 1 2009
End Date
September 1 2012
Last Update
October 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gynækologisk-Obstetrisk Afdeling, Sygehus Nord
Roskilde, Region Sjælland, Denmark, 4000